Australian (ASX) Growth Pharmaceuticals & Biotech Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Apr 16, 2025

Discover Australian Pharmaceuticals & Biotech Growth Stocks that are on the ASX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

82 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
TRJ Trajan Group Holdings	AU$0.76	-14.2%	-34.3%	AU$115.0m	AU$1.48	PB1.1x	E127.6%	n/a
BOT Botanix Pharmaceuticals	AU$0.40	6.8%	75.6%	AU$723.9m	n/a	PS349.9x	E114.3%	n/a
MYX Mayne Pharma Group	AU$7.05	0.7%	4.4%	AU$572.8m	AU$7.40	PS1.4x	E114.0%	n/a
LGP Little Green Pharma	AU$0.12	-4.2%	-17.9%	AU$34.9m	n/a	PS1.2x	E108.1%	n/a
ACR Acrux	AU$0.023	4.5%	-60.3%	AU$9.4m	n/a	PS11.7x	E106.9%	0%
MVP Medical Developments International	AU$0.45	-5.3%	-17.4%	AU$50.7m	AU$2.11	PS1.3x	E95.8%	0%
GSS Genetic Signatures	AU$0.41	1.2%	-41.4%	AU$93.1m	AU$1.05	PS5x	E86.2%	n/a
CYP Cynata Therapeutics	AU$0.20	0%	-7.1%	AU$44.1m	n/a	PS25.3x	E84.7%	n/a
MSB Mesoblast	AU$1.65	-4.9%	112.9%	AU$2.1b	AU$3.80	PS234.8x	E60.9%	n/a
VFY Vitrafy Life Sciences	AU$1.40	28.0%	n/a	AU$89.1m	AU$2.15	PB2.6x	E60.9%	n/a
ARX Aroa Biosurgery	AU$0.41	6.6%	-20.6%	AU$139.7m	n/a	PS2x	E60.4%	n/a
OPT Opthea	AU$0.60	0%	-4.8%	AU$738.8m	AU$1.07	PS2247.4x	E54.4%	n/a
ALA Arovella Therapeutics	AU$0.078	-3.7%	-32.2%	AU$92.3m	n/a	PS26.8x	E52.4%	n/a
IMC Immuron	AU$0.064	-3.0%	-36.0%	AU$14.9m	n/a	PS2.3x	E38.2%	n/a
TLX Telix Pharmaceuticals	AU$25.69	-3.3%	87.2%	AU$8.7b	AU$30.86	PE173.8x	E34.3%	n/a
PYC PYC Therapeutics	AU$1.03	1.5%	8.4%	AU$567.5m	AU$3.48	PS22.7x	E29.7%	n/a
EZZ EZZ Life Science Holdings	AU$1.58	19.7%	87.0%	AU$74.5m	AU$5.15	PE8.3x	E13.4%	2.5%
CSL CSL	AU$239.35	-1.0%	-11.8%	AU$115.9b	AU$311.59	PE26.8x	E13.0%	1.7%
CU6 Clarity Pharmaceuticals	AU$1.90	14.8%	-29.9%	AU$610.6m	AU$6.72	PS56.7x	E10.6%	n/a
IMU Imugene	AU$0.024	0%	-69.2%	AU$179.2m	n/a	PB2.8x	E8.9%	n/a
CUV Clinuvel Pharmaceuticals	AU$10.85	-0.09%	-29.0%	AU$541.9m	AU$24.63	PE14x	E6.9%	0.5%
NEU Neuren Pharmaceuticals	AU$10.53	10.0%	-46.5%	AU$1.3b	AU$24.97	PE9.3x	E4.7%	n/a
IMM Immutep	AU$0.23	-2.1%	-32.9%	AU$342.1m	AU$1.15	PS70.1x	E1.8%	n/a
RCE Recce Pharmaceuticals	AU$0.29	-3.3%	-43.7%	AU$67.2m	AU$2.46	PS7x	E-5.9%	n/a

Page 1 of 4